Myomo (MYO) Shares Outstanding (Diluted Average) (2021 - 2025)

Myomo (MYO) reported Shares Outstanding (Diluted Average) of $42.2 million for Q3 2025, up 12.87% on a YoY basis from $37.4 million in Q3 2024, and up 1.56% quarter-over-quarter from $41.5 million in Q2 2025.

Myomo (MYO) Shares Outstanding (Diluted Average) (2021 - 2025) Analysis & Trends

Myomo has reported Shares Outstanding (Diluted Average) for 5 years, with the latest figure at $42.2 million in Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding (Diluted Average) rose 12.87% year-over-year to $42.2 million; the trailing twelve-month figure through Sep 2025 stood at $42.2 million (up 12.87% YoY), and the FY2024 full-year result was $37.8 million, up 28.0% from the prior year.
  • Shares Outstanding (Diluted Average) for Q3 2025 stood at $42.2 million, up from $41.5 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $42.2 million in Q3 2025, with the low at $5.4 million in Q2 2021.
  • Historically, Shares Outstanding (Diluted Average) has averaged $23.7 million across 5 years, with a median of $26.8 million in 2023.
  • Annual changes were most pronounced in 2023 — Shares Outstanding (Diluted Average) soared 318.34% — and 2025, when it advanced 11.11%.
  • Myomo's Shares Outstanding (Diluted Average) stood at $5.8 million in 2021, then advanced by 20.94% to $7.1 million in 2022, then surged by 318.34% to $29.5 million in 2023, then rose by 28.0% to $37.8 million in 2024, then climbed by 11.68% to $42.2 million in 2025.
  • The last three Shares Outstanding (Diluted Average) figures came in at $42.2 million (Q3 2025), $41.5 million (Q2 2025), and $41.5 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.75 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 386.50 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 1.29 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1.50 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 580.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 393.60 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 457.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Myomo 49.44 Mn 31.04 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 42.17 Mn
Jun 30, 2025 41.52 Mn
Mar 31, 2025 41.45 Mn
Dec 31, 2024 37.76 Mn
Sep 30, 2024 37.36 Mn
Jun 30, 2024 37.37 Mn
Mar 31, 2024 36.75 Mn
Dec 31, 2023 29.50 Mn
Sep 30, 2023 27.54 Mn
Jun 30, 2023 26.00 Mn
Mar 31, 2023 24.20 Mn
Dec 31, 2022 7.05 Mn
Sep 30, 2022 7.06 Mn
Jun 30, 2022 6.92 Mn
Mar 31, 2022 6.89 Mn
Dec 31, 2021 5.83 Mn
Sep 30, 2021 5.68 Mn
Jun 30, 2021 5.42 Mn